Costs of illness and care in Parkinson's Disease: An evaluation in six countries

European Neuropsychopharmacology

Volumn 21, Issue 2, 2011, Pages 180-191

  von Campenhausen, Sonja ^a,b   Winter, Yaroslav ^a   Rodrigues e Silva, Antonio ^a   Sampaio, Christina ^c   Ruzicka, Evzen ^d   Barone, Paolo ^e   Poewe, Werner ^f   Guekht, Alla ^g   Mateus, Céu ^h   Pfeiffer, Karl P ^f   Berger, Karin ⁱ   Skoupa, Jana ^d   Bötzel, Kai ^b   Geiger Gritsch, Sabine ^j   Siebert, Uwe ^j,k   Balzer Geldsetzer, Monika ^a   Oertel, Wolfgang H ^a   Dodel, Richard ^a   Reese, Jens P ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d CHARLES UNIVERSITY   (Czech Republic)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^h UNIVERSIDADE NOVA DE LISBOA   (Portugal)

ⁱ Medical Economics Research Group   (Germany)

^j UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Care; Cost; Cost of illness; Economic burden; Europe; Parkinson's Disease

Indexed keywords

ANTIPARKINSON AGENT; APOMORPHINE; BENSERAZIDE PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE;

ADULT; AGED; ARTICLE; AUSTRIA; CAREGIVER; COST OF ILLNESS; CZECH REPUBLIC; DATA ANALYSIS; DRUG COST; FEMALE; GERMANY; HEALTH CARE UTILIZATION; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; INCOME; ITALY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTPATIENT CARE; PARKINSON DISEASE; PHYSIOTHERAPY; PORTUGAL; PRIORITY JOURNAL; REHABILITATION CARE; REIMBURSEMENT; RESOURCE MANAGEMENT; RUSSIAN FEDERATION; SOCIOECONOMICS; SPEECH THERAPY;

AMBULATORY CARE; ANTIPARKINSON AGENTS; COST OF ILLNESS; EUROPE; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LONG-TERM CARE; MALE; PARKINSON DISEASE; QUESTIONNAIRES;

EID: 78751624162     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.08.002     Document Type: Article

References (74)

1. Österreichische Arzneispezialitäten AMI-Arzneimittelinformation, Available at: accessed December 2005. http://www.ami-info.at/.
2. Andlin-Sobocki P., Jönsson B., Wittchen H.U., Olesen J. Cost of disorders of the brain in Europe. Eur. J. Neurol. 2005, 12(Suppl 1):1-27.
3. Honorarordnung für Ärzte für Allgemeinärzte und Fachärzte Ärztekammer für Tirol, Available at: accessed January 2006. http://www.aerzte4840.at/arzt/abrechnung/HonorarOrdnung_SVA.pdf.
4. Barber J.A., Thompson S.G. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat. Med. 2000, 19:3219-3236.
5. Barros P., de Almeira Simoes J. Portugal: health system review. Health syst. Trans. 2007, 9(5):1-140.
6. Sozialgesetzbuch I-XI 2003, Bundesministerium der Justiz, Bundesanzeiger Verlag, Köln/Limburg.
7. Leistungsorientierte Krankenanstaltfinanzierung-Leistungskatalog 2005 2005, Bundesministerium für Gesundheit und Frauen, Bundesministerium für Gesundheit und Frauen, Wien.
8. Rote Liste 2006 2006, Bundesverband der pharmazeutischen Industrie, Rote Liste Verlag, Weinheim.
9. Casado D., Garcia Gomez Pilar, Lopez Nicolas Angel Informal Care and Labour Force Participation among Middle-Aged Women in Spain (March 2007) 2007, Available at SSRN: http://ssrncom/abstract=1002906.
10. Catalogue of company "SIMS-2" 2005. Ltd. Moscow: "SIMS-2" Ltd 2005.
11. Catalogue of company Danner Available at, accessed January 2006. http://www.danner-gesund.at/.
12. Catalogue of company Kaphingst Available at, accessed January 2005. http://www.kaphingst-shop.de/.
13. Catalogue of company Med-Magazin 2005. Ltd. Med-Magazin 2005, Moscow.
14. Catalogue of company Setrans 2004. Prague.
15. Catalogue of the company Crom Ortopedia 2009. Available at: accessed May 2009. http://www.crom-ortopedia.it/.
16. Catalogue of the medical goods company Bastos Viegas 2008. Available at: accessed March 2008. http://www.bastosviegas.com/.
17. Panel-First Faculty of Medicine 2006, Charles University in Prague and General Hospital in Prague.
18. Chrischilles E.A., Rubenstein L.M., Voelker M.D., Wallace R.B., Rodnitzky R.L. The health burdens of Parkinson's disease. Mov. Disord. 1998, 13:406-413.
19. Czech Statistical Office, Available at: accessed November 2008. http://vdb.czso.cz/vdbvo/en/uvod.jsp.
20. Deutsche Rentenversicherung, Available at: accessed December 2006. http://www.deutsche-rentenversicherung.de/nn_15848/SharedDocs/de/Navigation/Rehabilitation/kliniken__node.html__nnn=true.
21. Dodel R.C., Singer M., Kohne-Volland R., Szucs T., Rathay B., Scholz E., Oertel W.H. The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis. Pharmacoeconomics 1998, 14:299-312.
22. Dorsey E.R., Constantinescu R., Thompson J.P., Biglan K.M., Holloway R.G., Kieburtz K., Marshall F.J., Ravina B.M., Schifitto G., Siderowf A., Tanner C.M. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007, 68:384-386.
23. Efron B., Tibshirani R. An Introduction to the Bootstrap 1993, Chapman and Hall, London.
24. Ehret R., Balzer-Geldsetzer M., Reese J.P. Direkte Kosten von Parkinson-Patienten in neurologischen Schwerpunkt-Praxen in Berlin. Der Nervenarzt 2009, 80:452-458.
25. Generic medicines in Europe European Generic Medicines Association, Available at: accessed May 2009. http://www.egagenerics.com.
26. Fahn S., Elton R. Recent developments in Parkinson's Disease II. Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease II 1987, 153-163. New York, Macmillan. S. Fahn, C.D. Marsden, D.B. Calne, M. Goldstein (Eds.).
27. Findley L., Aujla M., Bain P.G., Baker M., Beech C., Bowman C., Holmes J., Kingdom W.K., MacMahon D.G., Peto V., Playfer J.R. Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov. Disord. 2003, 18:1139-1145.
28. General Health Insurance Fund of the Czech Republic (GHIF CR) 2004. Code list of medicinal products.
29. Gibb W.R., Lees A.J. The significance of the Lewy body in the diagnosis of Idiopathic Parkinson's Disease. Neuropathol. Appl. Neurobiol. 1989, 15:27-44.
30. Hagell P., Nordling S., Reimer J., Grabowski M., Persson U. Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Mov. Disord. 2002, 17:1213-1220.
31. Hoehn M. Parkinsonism: onset, progression and mortality. Neurology 1967, 5:427-442.
32. Hofmarcher M., Rack H. Gesundheitssysteme im Wandel, Österreich 2006, Medizinisch Wissenschaftliche Verlagsgesellschaft OHG, Berlin.
33. Infarmed Prontuário Terapêutico available at: accessed November 2008. http://www.infarmed.pt/prontuario/index.php.
34. Fallpauschalenkatalog 2006 Institut für das Entgeltsystem im Krankenhaus (InEK), Available at: accessed September 2008. http://www.g-drg.de/cms/index.php/inek_site_de/Archiv/Systemjahr_2006_bzw._Datenjahr_2004#sm2.
35. Istituto nazionale di statistica, Available at: accessed July 2009. http://www.istat.it.
36. Keränen T., Kaakkola S., Sotaniemi K., Laulumaa V., Haapaniemi T., Jolma T., Kola H., Ylikoski A., Satomaa O., Kovanen J., Taimela E., Haapaniemi H., Turunen H., Takala A. Economic burden and quality of life impairment increase with severity of PD. Parkinsonism Relat. Disord. 2003, 9:163-168.
37. Keus S.H., Bloem B.R., Hendriks E.J., Bredero-Cohen A.B., Munneke M. Evidence-based analysis of physical therapy in Parkinson's disease with recommendations for practice and research. Mov. Disord. 2007, 22:451-460.
38. Koopmanschap M.A., Rutten F.F., van Ineveld B.M., van Roijen L. The friction cost method for measuring indirect costs of disease. J. Health Econ. 1995, 14:171-189.
39. Krauth C., Hessel F., Hansmeier T., Wasem J., Seitz R., Schweikert B. Empirical standard costs for health economic evaluation in Germany - a proposal by the working group methods in health economic evaluation. Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Ger.) 2005, 67:736-746.
40. Elsevier Masson S.r.l 2004, L'Informatore farmaceutico Medicinali.
41. LePen C., Wait S., Moutard-Martin F., Dujardin M., Ziegler M. Cost of illness and disease severity in a cohort of French patients with Parkinson's disease. Pharmacoeconomics 1999, 16:59-69.
42. Lindgren P., von Campenhausen S., Spottke E., Siebert U., Dodel R. Cost of Parkinson's disease in Europe. Eur. J. Neurol. 2005, 12(Suppl 1):68-73.
43. Martinez-Martin P., Forjaz M.J., Frades-Payo B., Rusinol A.B., Fernandez-Garcia J.M., Benito-Leon J., Arillo V.C., Barbera M.A., Sordo M.P., Catalan M.J. Caregiver burden in Parkinson's disease. Mov. Disord. 2007, 22:924-931.
44. McCrone P., Allcock L.M., Burn D.J. Predicting the cost of Parkinson's disease. Mov. Disord. 2007, 22:804-812.
45. Ministério do Trabalho e da Solidariedade Social (INE) 2005. Ganho médio mensal (€) por Sexo e Actividade económica. Available at: accessed November 2008. http://www.ine.pt.
46. Ministero della Salute 2003. Unique conventional rate for acute hospital assistence service (HCFA-DRG Versione 19°).
47. Official Tariff List for Outpatient Services "Nomenclatore Tariffario" 2004, Ministero della Salute.
48. Ministero della Salute Unique Conventional Rate for Rehabilitation Hospital Services 2006.
49. Ministry of Public Health and Social Development of Russian Federation Official State Price List of Drugs for 2005 2005, Ministry of Public Health and Social Development of Russian Federation, Moscow.
50. Ministry of Public Health and Social Development of Russian Federation Official Tariff List for Medical Services 2005 2005, Ministry of Public Health and Social Development of Russian Federation, Moscow.
51. Nijkrake M.J., Keus S.H., Oostendorp R.A., Overeem S., Mulleners W., Bloem B.R., Munneke M. Allied health care in Parkinson's disease: referral, consultation, and professional expertise. Mov. Disord. 2009, 24:282-286.
52. Health at a glance 2007: OECD indicators OECD, Available at: accessed Juli 2008. http://www.oecd.org/document/11/0,3343,en_2649_34631_16502667_1_1_1_1,00.html.
53. Purchasing Power Parities (PPPs) for OECD Countries 1980-2007: OECD 2008 OECD, Available at: accessed November 2008. http://www.oecd.org/dataoecd/61/56/39653523.xls.
54. Pensionsversicherungsanstalt Österreich 2006. Rahmenvertrag des Hauptverbandes der österreichischen Sozialversicherungsträger und Rehabilitationskliniken mit Sonderkrankenanstaltenstatus.
55. Portaria A110/2007 2007, 2-124. Portuguese Ministry of Health.
56. Contabilidade Analíticados hospitais de SNS de 2005 Portuguese Ministry of Health, Available, accessed March 2008. http://www.min-saude.pt/portal/conteudos/a+saude+em+portugal/publicacoes/revistas+e+boletins/analitica.htm.
57. Reese J.P., Winter Y., Balzer-Geldsetzer M., Botzel K., Eggert K., Oertel W.H., Dodel R., Campenhausen S.V. Parkinson's Disease: cost-of-Illness in an Outpatient Cohort. Gesundheitswesen 2010, [Electronic publication ahead of print].
58. Rokosova M, Háva P, Schreyögg J, Busse R, 2005. Czech Republic: health system review. Health Sys. Trans. 7 (1), 1-100.
59. Russian State Committee for Statistics, Available at: accessed Januar 2007. http://www.gks.ru/wps/portal/!ut/p/.
60. Schrag A., Jahanshahi M., Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov. Disord. 2000, 15:1112-1118.
61. Schrag A., Hovris A., Morley D., Quinn N., Jahanshahi M. Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat. Disord. 2006, 12:35-41.
62. Spottke A.E., Reuter M., Machat O., Bornschein B., von Campenhausen S., Berger K., Koehne-Volland R., Rieke J., Simonow A., Brandstaedter D., Siebert U., Oertel W.H., Ulm G., Dodel R. Cost of illness and its predictors for Parkinson's disease in Germany. Pharmacoeconomics 2005, 23:817-836.
63. Statistik Austria 2009. Statistisches Jahrbuch 2009. Available at: accessed January 2009. http://www.statistik.at/web_de/services/stat_jahrbuch/index.html.
64. Statistisches Bundesamt Deutschland 2008. Available at: accessed August 2008. http://www.destatis.de.
65. Catalogue of Healthcare Services 2002, The Czech Medical Chamber, Strategie, Czech Medical Chamber, Prague.
66. Tiroler Gebietskrankenkasse 2006. Tarifvereinbarungen TGGK und Physioaustria, Bundesverband der PhysiotherapeutInnen Österreichs.
67. Tragakes E., Lessof S. Health care systems in transition: Russian Federation. European Observatory on Health Systems and Policies 2003: 5 (3), Copenhagen 2003.
68. Verband der Angestelltenkrankenkassen und Arbeiter-Ersatzkassenverband 2006. Vergütungsliste für Krankengymnastische/physiotherapeutische Leistungen, Massagen und medizinische Bäder.
69. von Campenhausen S., Bornschein B., Wick R., Botzel K., Sampaio C., Poewe W., Oertel W., Siebert U., Berger K., Dodel R. Prevalence and incidence of Parkinson's disease in Europe. Eur. Neuropsychopharmacol. 2005, 15:473-490.
70. von Campenhausen S., Winter Y., Gasser J., Seppi K., Reese J.P., Pfeiffer K.P., Geiger-Gritsch S., Botzel K., Siebert U., Oertel W.H., et al. Cost of illness and health services patterns in Morbus Parkinson in Austria. Wien Klin Wochenschr 2009, 121(17-18):574-582.
71. Winter Y., von Campenhausen S., Popov G., Reese J.P., Klotsche J., Botzel K., Gusev E., Oertel W.H., Dodel R., Guekht A. Costs of Illness in a Russian Cohort of Patients with Parkinson's Disease. PharmacoEconomics 2009, 27(7):571-584.
72. Winter Y., von Campenhausen S., Brozova H., Skoupa J., Reese J.P., Botzel K., Eggert K., Oertel W.H., Dodel R., Ruzicka E. Costs of Parkinson's disease in Eastern Europe: a Czech cohort study. Parkinsonism Relat. Disord. 2010, 16(1):51-56.
73. Winter Y., Balzer-Geldsetzer M., Spottke A., Reese J.P., Baum E., Klotsche J., Rieke J., Simonow A., Eggert K., Oertel W.H., et al. Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany. Eur. J. Neurol. 2010, 17(17):1156-1163.
74. Home care in Europe - the solid facts World Health Organisation, available at: accessed September 2009. http://www.euro.who.int/InformationSources/Publications/Catalogue/20081103_2-13k.